Ellogon’s AI-driven cancer diagnostics solution quantifies oncology biomarkers in complex histopathological slides with limited annotations. Traditional supervised deep learning requires exhaustive annotation by pathologists, which is impractical due to the enormous size and complexity of histopathology slides. Ellogon however, uses sparse-shot learning to achieve high accuracy with significantly fewer annotations, making it a game-changer in the field of digital pathology.